ESMO Media Releases
Study Opens New Prospects for Developing Dew Targeted Therapies for Breast Cancer
A study led by prominent breast cancer experts from Europe and the US has revealed a number of potentially important prospects for targeted therapies, and brings opportunities of truly personalised therapy for breast cancer a step closer, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
Study confirms Everolimus can overcome Trastuzumab resistance in IN HER-2 positive early breast cancer
A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast cancers can develop to trastuzumab has left researchers contemplating a puzzle.
Gene expression test distinguishes between breast cancer patients at high and low risk of late recurrence
Study reveals magnitude of variation in gene expression measurements within breast cancers
An important new study has revealed the clearest picture yet of precisely how much measurement variation influences gene expression profiles of breast cancer.
Breast cancer heterogeneity no barrier to predictive testing, study shows
Breast cancers contain many different cell types with different patterns of gene expression, but a new study provides reassurance that this variability should not be a barrier to using gene expression tests to help tailor cancer treatments to individual patients.
ESMO supports World Cancer Day cautioning that the era of personalised cancer medicine is not here yet
Highlighting the need for more in-depth education and wider collaborations between researchers, oncologists and patients.
Cancer in the Movies
It’s time cinema directors realised cancer isn’t always a death sentence, a new study shows
Urgent need for integrated oncology and palliative care
ESMO 2012 emphasises palliative care: 16 new ESMO Designated Centres of Integrated Oncology and Palliative Care honoured New research providing snap-shot of palliative care in Italy
The true costs of cancer in Europe revealed
The first ever estimate of the economic burden of cancer in Europe shows that it exceeds 124 billion euros
ESMO 2012 Press Release: Myths and misunderstandings hamper efforts to prevent cancer
Studies presented at ESMO 2012 highlight challenges of cancer prevention